Achieve Life Sciences Files 8-K on Shareholder Vote Matters

TL;DR

ACHV filed an 8-K for a shareholder vote on June 5th.

AI Summary

Achieve Life Sciences, Inc. filed an 8-K on June 6, 2024, reporting on a submission of matters to a vote of security holders that occurred on June 5, 2024. The company, formerly known as OncoGenex Pharmaceuticals, Inc. and Sonus Pharmaceuticals Inc., is incorporated in Delaware and headquartered in Bothell, WA.

Why It Matters

This filing indicates a significant corporate event involving shareholder decisions, which could impact the company's future direction and stock performance.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of a shareholder vote, not indicating immediate financial distress or significant operational changes.

Key Players & Entities

• ACHIEVE LIFE SCIENCES, INC. (company) — Registrant
• June 5, 2024 (date) — Date of earliest event reported
• June 6, 2024 (date) — Date of Report
• Delaware (jurisdiction) — State of Incorporation
• Bothell, WA (location) — Address of Principal Executive Offices
• ONCOGENEX PHARMACEUTICALS, INC. (company) — Former Company Name
• SONUS PHARMACEUTICALS INC (company) — Former Company Name

FAQ

Key Financial Figures

• $0.001 — ch registered Common Stock, par value $0.001 per share ACHV The NASDAQ Capital M

Filing Documents

• achv-20240605.htm (8-K) — 82KB
• 0000950170-24-069973.txt ( ) — 234KB
• achv-20240605.xsd (EX-101.SCH) — 50KB
• achv-20240605_htm.xml (XML) — 6KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. The Annual Meeting of Stockholders of Achieve Life Sciences, Inc. (the "Company") was held on June 5, 2024. The following is a brief description of each matter voted upon and the certified voting results. (1) Election of eight directors to serve until the Company's next annual meeting or until the directors' successors are duly elected and qualified: For Withhold Broker Non-Votes John Bencich 14,570,909 456,303 10,246,712 Stuart Duty 14,088,063 939,149 10,246,712 Vaughn Himes 14,600,768 426,444 10,246,712 Cindy Jacobs 14,498,319 528,893 10,246,712 Thomas B. King 14,095,642 931,570 10,246,712 Bridget Martell 14,159,031 868,181 10,246,712 Thomas Sellig 14,605,590 421,622 10,246,712 Richard Stewart 14,516,198 511,014 10,246,712 Pursuant to the foregoing votes, the nominees listed above were elected as directors to serve on the Company's board of directors. (2) Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024: For Against Abstain Broker Non-votes 24,825,016 230,631 218,277 — Pursuant to the foregoing votes, the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified. ________________________

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ACHIEVE LIFE SCIENCES, INC. Date: June 6, 2024 /s/ John Bencich John Bencich Chief Executive Officer (Principal Executive and Financial Officer)

View Full Filing

View this 8-K filing on SEC EDGAR